Mefitel film for radiation dermatitis: it works, why not?

Published Date: 13 Mar 2023

According to the results of a phase 3 trial, the use of silicone film before radiotherapy can reduce the incidence of radiodermatitis, so why not use it?

Read Full News

Latest News

Weight-Loss Drug-Biologic Combo Boosts Relief in PsA

ACR50 scores improve when tirzepatide is added to ixekizumab in higher-BMI group, in two trials.

CLL Tied to Increased Skin Cancer Risk Over 10 Years

Patients with chronic lymphocytic leukemia show higher risks for skin cancer, as well as skin cancer-specific metastasis and death.

TYK2 inhibitor Promising for Psoriasis in Phase 3 Studies

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety concerns emerging.

EU Backs Targeted BRAF Combo in Melanoma, Thyroid Cancer

European authorities have backed a targeted BRAF/MEK inhibitor combo for radioactive iodine-refractory thyroid cancer and extended its use to adolescents with advanced or resected melanoma.

Incyte's Skin Disease Drug Shows Long-term Symptom Relief in Late-stage Trials

Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in ⁠two late-stage trials.

Superficial Radiation Tx Costs Exceed Mohs Surgery for NMSC

Image-guided superficial radiation therapy remains a higher-cost treatment than Mohs surgery for nonmelanoma skin cancer, a retrospective study shows.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Latest News

ACR50 scores improve when tirzepatide is added to ixekizumab in higher-BMI group, in two trials.

Patients with chronic lymphocytic leukemia show higher risks for skin cancer, as well as skin cancer-specific metastasis and death.

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety concerns emerging.

European authorities have backed a targeted BRAF/MEK inhibitor combo for radioactive iodine-refractory thyroid cancer and extended its use to adolescents with advanced or resected melanoma.

Incyte said on Saturday its experimental skin disease drug showed long-term reduction of symptoms in ⁠two late-stage trials.

Image-guided superficial radiation therapy remains a higher-cost treatment than Mohs surgery for nonmelanoma skin cancer, a retrospective study shows.

News All Time

Higher Mortality Risk Seen in axSpA, PsA in Real-World Study

Patients with axial spondyloarthritis and psoriatic arthritis face an elevated risk for all-cause mortality compared with the general population, and the risk is reduced with b/tsDMARD treatment.

Do Diet Trends Improve Health? A Clinical Take

Learn which diet trends have scientific support — clean eating, detox, glow food and plant-based diets influence health differently and require individualized clinical counseling.

Exclusive-Child Vaccination Rate Drops Sharply in Michigan as RFK Jr Influences Policy

Vaccination rates among young children in Michigan dropped sharply during the first year of the Trump administration, a Reuters analysis of state data shows, providing an...

FDA Approves Icotrokinra for Moderate-to-Severe Psoriasis

This is the first IL-23 receptor-targeted oral peptide pill, and it is also being evaluated as a treatment for psoriatic arthritis, ulcerative colitis, and Crohn’s disease.

Lutikizumab Offers Relief for Refractory HS

Lutikizumab improves clinical responses and pain outcomes in patients with hidradenitis suppurativa after anti-TNF failure in a phase 2 study.

Novo Nordisk Patent Expiry Opens Door to Cheaper Weight-Loss Drugs in India

India’s diabetes and weight-loss drug market faces a shake-up as Novo Nordisk’s semaglutide patent expires, opening the door to cheaper generics.

FDA OKs Linerixibat for Cholestatic Pruritus

The oral ileal bile acid transporter inhibitor significantly and rapidly reduced cholestatic pruritus in patients with PBC in the phase 3 GLISTEN trial.

Distinct Comorbidity Pattern Hinders Remission in Lupus

Patients with lupus face a high burden of comorbidities, with the presence of at least one of seven key conditions linked to 55%-60% lower odds of achieving remission or a low disease activity state.

Children With Autism Face Growing Unmet Healthcare Needs

A cross-sectional study examines annual trends in unmet healthcare needs among over 8000 children with autism.

HSV-1 May Be Increasing in Infants

A new study suggests that HSV-1 has become the dominant subtype among newborns.

Secukinumab Gets FDA Nod for Adolescent HS

Weight-based injectable’s approval is based in part on other pediatric indications.

Low-Beta Radiation Patch Offers Alternative NMSC Treatment

Similar to brachytherapy, OncoPatch could be an option for patients who have superficial lesions or who aren’t surgical candidates.

What Does FDA Food Pyramid Mean for Cancer Risk and Care?

Much of the new FDA food guidance aligns with existing advice, but some areas may introduce confusion to advising patients on diet and cancer prevention and survival.

UK Approves New JAK Inhibitor for Severe Alopecia

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on NHS access.

Tildrakizumab Now Under FDA Review for Psoriatic Arthritis

Full results from the pivotal trials submitted to support approval have not yet been reported.

Early Intensive Therapy Best for PsA With Poor Prognosis

Early intensive treatment for PsA with csDMARDs or 6 months of TNFi is superior to standard step-up care, and better outcomes were maintained at 48 weeks in the TNFi group.

Recommended News For You

Clinical trial is testing whether heavy lifting could combat cancer side effects

Skinny melanoma incidence is associated with vitamin D deficiency.

CAR-T Warning for Secondary Malignancies: Warranted or Not?

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

EMA OKs Two Treatments for Small Cell Lung Cancer

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

Recommended Articles For You

Unlocking the Mystery of Leukemia: Exploring New Treatments and Hope for Patients 

Liquid Biopsies and ctDNA: Transforming Cancer Detection, Monitoring, and Clinical Decisions 

Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection 

Understanding Purpura Fulminans: Causes, Symptoms and Treatment Options 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Tumor characteristics found to differ for melanomas in children, teens and young adults

2.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

3.

After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.

4.

In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.

5.

Researchers discover cellular 'doorway' exploited by cancer-causing virus

1.

Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies

2.

Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives

3.

Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care

4.

Discovering the Benefits of TNK: A Comprehensive Blog Article 

5.

Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

2.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

3.

Efficient Management of First line ALK-rearranged NSCLC - Part V

4.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

5.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot